MedTrace Logo

Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula

NCT02425423 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-04-24

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy of a new thickened formula on regurgitation.

Conditions

  • Gastroesophageal Reflux

Interventions

DIETARY_SUPPLEMENT

New thickened formula

Sponsors & Collaborators

  • United Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Yvan Vandenplas, MD · Universitair Ziekenhuis Brussel

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
5 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-03-31
Completion
2014-06-30

Countries

  • Belgium
  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02425423 on ClinicalTrials.gov